Lab-on-a-Chip– tag –
-
Market Trends
Brazilian Deeptech Doroth Raises US$4.5 Million to Build Latin America’s First Microfluidic Chip Plant, Targeting 4 Million Annual Production
Latam Republic Brazil Overview Brazilian deeptech company Doroth has raised US$4.51 million to construct Latin America's first microfluidic chip manufacturing facility, aiming for an annual capacity of up to 4 million chips. This strateg... -
New Technology
Twisted Light Unlocks Faster, Ultra-Sensitive Disease Detection from Minute Samples
ARTIC Australia Overview Adelaide University has pioneered a groundbreaking 'twisted light' technology, promising significantly faster and more sensitive medical diagnostics, particularly with minuscule sample volumes. This innovation, l... -
New Technology
PMC Reviews Microfluidic Tools for Delineating NK Cell Biology, From Single-Cell Analysis to 3D Micro Physiological Systems, Integrating Cancer Cell Targets
PMC USA Overview A comprehensive review published in PMC on September 7, 2026, assesses the innovative progress of microfluidic technologies for studying Natural Killer (NK) cell biology. The paper focuses on single-cell phenotypic and f... -
New Technology
MilliporeSigma’s FemtoQuest System with SMC Technology Detects Ultra-Low Biomarkers in 15 Minutes
Facebook (SMC technology) USA Overview MilliporeSigma announced its FemtoQuest system, an improved 3rd generation instrument featuring Single Molecule Counting (SMC) technology, enhances researchers' ability to detect ultra-low levels of... -
New Technology
Abingdon Health Showcases Future of POCT: Genalyte Merlin Runs 26 Tests in 30 Minutes, Oasis Diagnostics Offers Non-Invasive Saliva Systems
Abingdon Health UK Overview Abingdon Health announced innovations in next-generation Point-of-Care Diagnostics (POCT), highlighting Genalyte’s Merlin instrument, which received FDA clearance for a TSH assay in 2024 and can now perform up... -
New Technology
CRISPR-Microfluidic Platforms Integrate On-Chip Lysis and Multiplexed Detection for Rapid POCT Pathogen Detection via Nucleic Acid Amplification Tests
AIP Publishing (Review Article) International Overview This review article highlights advances in microfluidic systems for POCT pathogen detection using Nucleic Acid Amplification Tests (NAAT). Specifically, it demonstrates the ability o... -
New Technology
POCT Innovations Accelerate at MEDICA 2026: Biosensors, Imaging AI, and Lab-on-a-Chip Drive Precision Medicine
MEDICA Germany Overview MEDICA 2026 highlights significant advancements in Point-of-Care Testing (POCT), accelerating on-site diagnostics for rapid clinical decision-making. Progress in biosensors, imaging AI, biomarkers, and lab-on-a-ch... -
Market Trends
Labman Develops Next-Gen POCT HPV Screening Device under EU ELEVATE Project: Rapid Detection of 14 HPV Strains and Two Biomarkers
News-Medical.net UK Overview Labman has developed a next-generation point-of-care (POCT) HPV screening device as part of the EU-funded ELEVATE project. This compact, portable instrument utilizes microfluidic 'lab-on-a-chip' technology to... -
Market Trends
BIOSENSOR 2026 Conference Unveils Key Topics of Interest: Featuring Lab-on-a-Chip, Nanobiosensors, Proteomics for Cancer Cell Detection, and Single-Cell Analysis
BIOSENSOR 2026 - 7th International Congress on Biosensors Unknown Overview The 7th International Congress on Biosensors, BIOSENSOR 2026, has announced its key Topics of Interest ahead of the August 16, 2026, abstract submission deadline.... -
New Technology
Lab-on-a-Chip & Microfluidics World Congress 2026 to Focus on POCT, Rapid Diagnostics, and Organ-on-a-Chip Technologies
SelectBIO Conferences Unknown Overview The SelectBIO Lab-on-a-Chip and Microfluidics World Congress 2026, scheduled for October 27-28, has been announced. This conference will specifically focus on Point-of-Care Testing (POCT), rapid dia...
12